Cargando…
Second primary malignancies among cancer patients
BACKGROUND: Rate of second primary malignancies (SPM) is steadily increasing over the last decades. New therapies, early diagnostic markers, screening tests for a larger number of individuals contribute to the increase prevalence of SPM. In the current study, we try to described the demographic comp...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290649/ https://www.ncbi.nlm.nih.gov/pubmed/32566575 http://dx.doi.org/10.21037/atm-20-2059 |
_version_ | 1783545727076532224 |
---|---|
author | Zheng, Xuanqi Li, Xiao Wang, Minqi Shen, Jianfei Sisti, Giovanni He, Zelai Huang, Jinfeng Li, Yan Michael Wu, Aimin |
author_facet | Zheng, Xuanqi Li, Xiao Wang, Minqi Shen, Jianfei Sisti, Giovanni He, Zelai Huang, Jinfeng Li, Yan Michael Wu, Aimin |
author_sort | Zheng, Xuanqi |
collection | PubMed |
description | BACKGROUND: Rate of second primary malignancies (SPM) is steadily increasing over the last decades. New therapies, early diagnostic markers, screening tests for a larger number of individuals contribute to the increase prevalence of SPM. In the current study, we try to described the demographic composition of SPM victims, distribution of primary sites, and the impact of related factors on prognosis. METHODS: We conducted a retrospective study identifying patients over the age of 18 who were diagnosed with SPM from the 16 most common cancer sites between 2000 and 2013 from Surveillance, Epidemiology, and End Results data. Cox proportional hazards regression was used to analyze the relationship between different factors associated to the prognosis of SPM. Standard incidence rate of multiple primary (MP-SIR) was also calculated. RESULTS: A total of 303,753 patients were diagnosis with SPM and 76,168 of whom (25.08%) were included in our analytic cohort. Patients with prostate cancer was vulnerable to SPM, accounting for 34.59%, and SPM was prone to occur in lung and bronchus, accounting for 24.90%. The heat map shows that esophagus cancer survivors have the highest risk of developing stomachache tumors (SIR =5.08). The result of Cox regression suggests that a history of liver was associated with the shortest survival time (HR =1.64, 95% CI, 1.54–1.75, P<0.001). CONCLUSIONS: With the advancement of medical standards, the survival time of cancer patients is prolonged, but the occurrence of SPM is also increasing, and the prognosis is not optimistic. More attention needs to be invested in the prevention and treatment of SPM. |
format | Online Article Text |
id | pubmed-7290649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-72906492020-06-19 Second primary malignancies among cancer patients Zheng, Xuanqi Li, Xiao Wang, Minqi Shen, Jianfei Sisti, Giovanni He, Zelai Huang, Jinfeng Li, Yan Michael Wu, Aimin Ann Transl Med Original Article BACKGROUND: Rate of second primary malignancies (SPM) is steadily increasing over the last decades. New therapies, early diagnostic markers, screening tests for a larger number of individuals contribute to the increase prevalence of SPM. In the current study, we try to described the demographic composition of SPM victims, distribution of primary sites, and the impact of related factors on prognosis. METHODS: We conducted a retrospective study identifying patients over the age of 18 who were diagnosed with SPM from the 16 most common cancer sites between 2000 and 2013 from Surveillance, Epidemiology, and End Results data. Cox proportional hazards regression was used to analyze the relationship between different factors associated to the prognosis of SPM. Standard incidence rate of multiple primary (MP-SIR) was also calculated. RESULTS: A total of 303,753 patients were diagnosis with SPM and 76,168 of whom (25.08%) were included in our analytic cohort. Patients with prostate cancer was vulnerable to SPM, accounting for 34.59%, and SPM was prone to occur in lung and bronchus, accounting for 24.90%. The heat map shows that esophagus cancer survivors have the highest risk of developing stomachache tumors (SIR =5.08). The result of Cox regression suggests that a history of liver was associated with the shortest survival time (HR =1.64, 95% CI, 1.54–1.75, P<0.001). CONCLUSIONS: With the advancement of medical standards, the survival time of cancer patients is prolonged, but the occurrence of SPM is also increasing, and the prognosis is not optimistic. More attention needs to be invested in the prevention and treatment of SPM. AME Publishing Company 2020-05 /pmc/articles/PMC7290649/ /pubmed/32566575 http://dx.doi.org/10.21037/atm-20-2059 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Zheng, Xuanqi Li, Xiao Wang, Minqi Shen, Jianfei Sisti, Giovanni He, Zelai Huang, Jinfeng Li, Yan Michael Wu, Aimin Second primary malignancies among cancer patients |
title | Second primary malignancies among cancer patients |
title_full | Second primary malignancies among cancer patients |
title_fullStr | Second primary malignancies among cancer patients |
title_full_unstemmed | Second primary malignancies among cancer patients |
title_short | Second primary malignancies among cancer patients |
title_sort | second primary malignancies among cancer patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290649/ https://www.ncbi.nlm.nih.gov/pubmed/32566575 http://dx.doi.org/10.21037/atm-20-2059 |
work_keys_str_mv | AT zhengxuanqi secondprimarymalignanciesamongcancerpatients AT lixiao secondprimarymalignanciesamongcancerpatients AT wangminqi secondprimarymalignanciesamongcancerpatients AT shenjianfei secondprimarymalignanciesamongcancerpatients AT sistigiovanni secondprimarymalignanciesamongcancerpatients AT hezelai secondprimarymalignanciesamongcancerpatients AT huangjinfeng secondprimarymalignanciesamongcancerpatients AT liyanmichael secondprimarymalignanciesamongcancerpatients AT wuaimin secondprimarymalignanciesamongcancerpatients AT secondprimarymalignanciesamongcancerpatients |